Jessica Hopfield is Director of Editas Medicine, Inc.. Currently has a direct ownership of 67,700 shares of EDIT, which is worth approximately $81,917. The most recent transaction as insider was on May 13, 2024, when has been sold 45,000 shares (Common Stock) at a price of $5.64 per share, resulting in proceeds of $253,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.7K
0% 3M change
198.24% 12M change
Total Value Held $81,917

Jessica Hopfield Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Open market or private purchase
$253,800 $5.64 p/Share
45,000 Added 39.93%
67,700 Common Stock
Mar 03 2021
BUY
Open market or private purchase
$263,958 $45.51 p/Share
5,800 Added 20.35%
22,700 Common Stock

Also insider at

MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Healthcare
PODD
INSULET CORP Healthcare
BLI
Berkeley Lights, Inc. Healthcare
JH

Jessica Hopfield

Director
Emeryville, CA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Track Activities on EDIT